Intel Commences Fight against Cancer with the Help of Technology and Data Analytics

By CIOReview | Thursday, September 3, 2015
808
1226
274

FREMONT, CA: Intel and the Knight Cancer Institute at Oregon Health & Science University (OHSU) have come up with a pilot network, allowing healthcare facilities to securely share genomic data for supporting cancer research and personalized medicine. This will cut short the time by days or hours for finding answers to questions which usually take weeks and months to decipher.

Through the new Collaborative Cancer Cloud, huge amounts of patient genomic data from different sites can be collected, analyzed and shared while keeping the terms of privacy and security of the patient data in individual sites. The research cloud scales ‘needle in the haystack’ in order to search for personalized treatments which successfully responded on patients with similar cancer writes Lucas Mearianin on an article for Computer World.

The personalized or ‘precision’ medicine provides treatments to the cancer effected patients independently with regards to their specific genome sequencing. This will save patients from excess exposure to chemotherapy thereby protecting the healthy cells. 

Intel has already made plans to make open-source,its Trusted Execution Technology in the first quarter of 2016.The firmware enables server CPUs to exchange encrypted data, which in turn protects patient privacy.

"If we're seeing 5,000 new cancer patients a year, many of them may get sequenced three or four times a year, we won't be able to ship all that data to a central location. We have all our Alzheimer's, MS patients and cardiac patients. We'll be sequencing 1,000 patients a day in our clinics,"says Dr. Brian Druker, Director,OHSU's Knight Cancer Institute.

The patients seeking cancers and genomics similar to their own will be helped with the Collaborative Cancer Cloud by allowing physicians to send out secure electronic queries to other healthcare facilities. Once a match is discovered, all electronic patient data is made anonymous before the data is analyzed. As per the institute, technology will allow healthcare centers to maintain control of patient data, while allowing clinics around the world to exchange data for genomic analysis.